Icon PLC
🇮🇪Ireland
- Country
- 🇮🇪Ireland
- Ownership
- Public
- Established
- 1990-01-01
- Employees
- 41.1K
- Market Cap
- $26.9B
- Website
- http://www.iconplc.com
- Introduction
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland...
Global Oncology Based In Vivo (CRO) Market By Sources Analysis, Share, Trends, Size
The Global Oncology Based In Vivo (CRO) Market is projected to grow from USD 2.07 Billion in 2024 to USD 3.61 Billion by 2031, driven by increasing cancer prevalence, biotechnology advances, and R&D investments. Key challenges include high costs, model limitations, ethical considerations, and data standardization issues. North America leads the market, while Asia Pacific shows the fastest growth. Major players include Charles River Laboratory, ICON Plc, and Thermo Fisher Scientific.
Biospecimen Contract Research Services Market Surge: Key Developments and Forecasts
The Biospecimen Contract Research Services Market is expected to grow at a CAGR of 9.3% from 2024 to 2031, driven by increased pharmaceutical R&D spending, clinical trials, and outsourcing needs. North America leads the market, with key players including BioChain Institute, BioIVT, and Azenta Life Sciences.
RNA Therapy Clinical Trials Market Expected to Grow to $3.32 Billion by 2031
The global RNA Therapy Clinical Trials Market is projected to reach $3.32 billion by 2031, driven by mRNA-based COVID-19 vaccines and increasing investments in RNA therapeutics. Challenges include efficient RNA delivery and IP protection. North America leads in market share due to robust research infrastructure and government support.
© Copyright 2024. All Rights Reserved by MedPath